It’s Centre vs states, once again
AIDCOC says the proposed joint inspections of pharma manufacturing facilities by drug inspectors of the state and centre will lead…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Editor’s note
Will 2018 be the turning point?
Besides analysing the past, we need to plan for the future
Time for a new strategy?
According to a recently released CII report, “Indian Roots, American Soil,” the life sciences, pharmaceuticals, and healthcare…
Who’s next, after Torrent-Unichem?
After a search that reportedly lasted a decade, Unichem Laboratories finally settled on Torrent Pharma as the best choice to sell…
Converting growth potential into a reality
This year's CPhI Annual Report released a ranking of countries as pharmaceutical destinations on various parameters
Balancing volumes with value
When the going gets tough, the tough get going. This adage could well describe the beleaguered pharma exporters of India
What ails India’s pharma exports?
It is no secret that declining pharmaceuticals exports have been worrying not just pharma honchos but the Prime Minister’s Office…
A double whammy for the sector?
As expected, the August 30 meeting called by the Department of Pharmaceuticals (DoP) to discuss the Draft Pharmaceutical Policy…
Draft pharma policy: Old wine in a new bottle?
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing 'more…
Surviving serialisation
It was way back in 1963 that the US FDA finalised the first version of Good Manufacturing Practices (GMPs) for finished…
India Pharma Inc’s tryst with destiny continues
As we mark our 71st Independence Day this August 15, how far have we progressed on the medicines security front?
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…
Racing against the GST deadline
The May update on pharma channel sales was gloomy at best, according to AIOCD PharmaTrac
Dull Q4FY17 could be a blessing in disguise
According to a report from CARE Ratings on the corporate performance of Q4FY17, the pharmaceuticals and drugs sector in India,…
Towards sustainability
Sustainability measures achieve the twin benefits of reducing operating costs while simultaneously meeting environmental goals
Bridging the skills gap
Beleaguered by warning letters and import recalls, pharmaceutical companies in India seem to be finally investing in upskilling…
Passing the buck?
Prime Minister Modi’s announcement that his government would ensure doctors prescribed generic medicines stirred a hornet’s nest
Does IP build or block?
Its been 17 years since the World Intellectual Property Organisation (WIPO) started marking April 26 as World Intellectual…
US-India relationship: Can it trump the odds?
Affordable and efficient healthcare systems is listed out as an area chosen for “Growing Convergence, Collaboration &…
Collaborate to conquer
Two rulings in the space of as many days demonstrate the fine balance required of India’s legal system when it comes to the…